Remove Clinical Research Remove Clinical Supply Remove Pharmaceuticals
article thumbnail

[Webinar] How biotech companies can improve clinical supply planning and distrib…

The Pharma Data

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.

article thumbnail

A Closer Look At Our On-Site Compounding Pharmacies

Alta Sciences

Clinical Supply Manufacturing Integration with our manufacturing team, ensuring flexibility and adaptability to meet the evolving needs of your studies throughout your drug development program or study. . - Fully equipped to support all types of IP administration forms.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

The Pharma Data

Management of the Company believe that the proposed acquisition will strengthen PharmaDrug’s product pipeline, intellectual property portfolio and pharmaceutical development expertise. Sairiyo is currently focused on advancing the clinical development of Cepharanthine to treat rare cancer diseases. About PharmaDrug Inc.

FDA 52
article thumbnail

Molecular Partners Announces Collaboration With Novartis to Develop Two DARPin(R) Therapies Designed for Potential Use Against COVID-19

The Pharma Data

During the clinical development stage, Molecular Partners will provide clinical supply. The companies will work together to scale-up manufacturing capacity, in collaboration with Sandoz, the generics and biosimilar Novartis division, to provide worldwide supply. . ” Collaboration Terms and Share Subscription.

article thumbnail

The golden era of GLP-1 drugs: How will it impact medicine and society?

BioPharma Drive: Drug Pricing

As a gastroenterologist for 35 years, with 25 of those spent in clinical research and seven at Altasciences , I recognize that GLP-1s may be one of the most significant medical advancements of our time—a treatment poised to redefine metabolic disease management.

article thumbnail

[Podcast] Trial Trailblazers: Behind clinical breakthroughs

BioPharma Drive: Drug Pricing

But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes. But the steady expansion of their use has slowed and, despite much trying, pharmaceutical companies have largely failed to top the drugs’ successes.

Trials 130
article thumbnail

Transforming cancer care through clinical excellence

Drug Target Review

I worked to continually grow my expertise, responsibility, and leadership before ultimately taking on my current role as Senior Vice President and Global Head of Clinical Operations at BeOne. Could you share an example of a specific project or research that you have worked on and the impact it has had in your field?